Causes of Transaminitis (Elevated Liver Enzymes)
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of transaminitis in developed countries, affecting up to 70% of obese patients and 90% of diabetics, followed by medication-induced liver injury (8-11% of cases), alcohol-related liver disease, and viral hepatitis. 1, 2, 3
Most Common Causes
Nonalcoholic Fatty Liver Disease (NAFLD)
- NAFLD is strongly associated with metabolic syndrome components including obesity, type 2 diabetes, hypertension, and hypercholesterolemia 3
- Typically presents with AST:ALT ratio <1 and mild to moderate transaminase elevations 1, 3
- Ultrasound has 84.8% sensitivity and 93.6% specificity for detecting moderate to severe hepatic steatosis (>30% fat content), though it misses mild steatosis when <20-30% of hepatocytes are affected 1, 3
Medication-Induced Liver Injury (DILI)
- Accounts for 8-11% of cases with mildly elevated liver enzymes 1, 2
- Common hepatotoxic medications include methotrexate, NSAIDs, statins, anticonvulsants, antiarrhythmics, tamoxifen, nitrofurantoin, minocycline, and infliximab 2
- Herbal supplements and over-the-counter products are frequently overlooked causes 1, 2
- Cholestatic drug-induced injury comprises up to 61% of cases in patients ≥60 years 3
Alcohol-Related Liver Disease
- Typically presents with AST:ALT ratio >2 (often >3), with mean AST around 152 U/L and ALT around 70 U/L 2
- Defined as ≥14-21 drinks/week in men or ≥7-14 drinks/week in women 3
- In alcoholic hepatitis, 70% of patients demonstrate AST:ALT ratio >2, and >98% have ratio >1.5 in histologically proven cases 2
Viral Hepatitis
- Chronic hepatitis B and C commonly present with fluctuating transaminase elevations over months 2
- Acute viral hepatitis typically shows higher elevations (>400 IU/mL for hepatitis A, B, C, D, or E) 2
- Chronic hepatitis B reactivation presents with elevated, often fluctuating ALT levels and moderate fluctuating HBV DNA levels >2000 IU/mL 2
Less Common but Important Causes
Autoimmune Hepatitis
- Presents with persistently elevated transaminases, hyperglobulinemia, and positive autoantibodies (ANA, ASMA, anti-LKM1) 2, 3
- Affects women 3-4 times more than men 2
- Approximately 30% of cases have cirrhosis at presentation 2
- Can present acutely with jaundice and markedly elevated transaminases 2
Hereditary Hemochromatosis
- Requires screening with fasting transferrin saturation and ferritin 1, 2
- Iron overload can cause persistent transaminitis even without other clinical manifestations 2
Celiac Disease
- Associated with transaminase elevations that improve or normalize with a gluten-free diet in 75-100% of cases 2
Alpha-1 Antitrypsin Deficiency
- Can present with chronic hepatitis, cirrhosis, or asymptomatic enzyme elevation 2
- Requires alpha-1 antitrypsin phenotyping (not just serum levels) for definitive diagnosis 2
Wilson Disease
- Must be excluded in patients under 40 years old with unexplained liver enzyme elevation 2
- Can present with isolated transaminitis 2
- Requires ceruloplasmin level and 24-hour urine copper collection if ceruloplasmin is low-normal 2
Non-Hepatic Causes to Exclude
Muscle Disorders
- Recent strenuous exercise, rhabdomyolysis, or polymyositis can elevate AST more than ALT 3
- Check creatine kinase (CK) to exclude muscle origin, as AST is present in cardiac muscle, skeletal muscle, kidneys, brain, and red blood cells 1, 2
Thyroid Disease
- Both hypothyroidism and hyperthyroidism can affect liver enzymes 3
- Screen with TSH in all patients with unexplained transaminitis 3
Cardiac Conditions
- Congestive heart failure can cause hepatic congestion and transaminitis 2
- Ischemic hepatitis presents with extremely elevated transaminases 4
HIV-Related Causes
- HIV-infected patients have multiple risk factors including coinfection with hepatitis B and C viruses, alcohol abuse, ART hepatotoxicity, HIV itself, and metabolic comorbidities leading to NAFLD 5
Context-Specific Causes
In Cancer Patients
- Immune checkpoint inhibitor-induced liver injury (ILICI) is a distinct cause 2
- Primary liver tumors or hepatic metastases, biliary obstruction, systemic infection, or sepsis 2
Statin-Induced Transaminitis
- Elevated hepatic transaminases occur in 0.5% to 2.0% of cases and are dose-dependent 6
- Progression to liver failure specifically due to statins is exceedingly rare if it ever occurs 6
- Reversal of transaminase elevation is frequently noted with dose reduction 6
- Statins are not contraindicated in chronic stable liver disease like NAFLD 2
Critical Clinical Pearls
ALT is more liver-specific than AST because it is primarily concentrated in liver tissue with minimal presence in cardiac muscle, skeletal muscle, or red blood cells. 1, 2, 3
- Normal ALT ranges are sex-specific: 29-33 IU/L for men and 19-25 IU/L for women, significantly lower than commercial laboratory cutoffs 1, 2
- Mild elevations (>1x to <3x ULN) without bilirubin elevation are often non-specific and may be related to NAFLD, dietary changes, or vigorous exercise 2
- Normal ALT does not exclude significant liver disease; up to 10% of patients with advanced fibrosis have normal ALT using conventional thresholds 1
- Approximately 50% of HCV-infected patients have normal transaminases 2
- Discrepancies between patient-reported and documented medications exist in >50% of patients with liver disease, particularly those taking more than five medications 2